ENvue Medical (FEED) has completed the transition of its NanoVibronix manufacturing operations to US from Israel and has further consolidated its research and development capabilities in Tel Aviv, Israel, the company said Tuesday.
The move supports the company's initiative to reduce its operating expenses and improve its cost structure, ENvue Medical said.